Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer’s disease: relevance for precision medicine in neurodegenerative diseases

Simone Lista(University of Rome Tor Vergata), Robert Nisticò(European Brain Research Institute)
Ageing Research Reviews
December 13, 2022
Cited by 40


Related Papers

Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis
|Philosophical Transactions of the Royal Society B Biological Sciences|2013|53